AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) shares surged higher on Friday after the company reaffirmed its status as a COVID-19 stock. The company announced that it has been validating the approved COVID-19 antibody test for commercial use in its lab in San Jose, California.
Note that this antibody test previously received the FDA’s Emergency Use Authorization. The validation is expected to be completed in the second half of 2020.
Management noted that as COVID-19 cases are still on the rise and there is no clear short-term containment in sight, COVID-19 tests likely will have both long-term and widespread demand. As such, the company is fully committed to validating the aforementioned approved COVID-19 antibody test.
CEO Chris Yu noted that the pending commercialization of the approved COVID-19 antibody test would be another major new product and service that AnPac Bio offers that would accelerate revenue growth.
AnPac Bio is biotech company focused on early cancer screening and detection with operations in both China and the United States.
As for the stock move, companies tend to get a boost whenever they mention any developments around COVID-19, rather like the similar trend with “blockchain” last year. While AnPac Bio only trades an average of roughly 13,000 shares per day, about 13 million shares had moved in Friday’s session.
Excluding Friday’s move, AnPac Bio stock had lost about 51% year to date, notching a loss of 27% over the past quarter alone.
AnPac Bio-Medical Science stock traded up about 50% to $8.22 on Friday, in a 52-week range of $5.03 to $12.18. The consensus price target is $18.00
The Average American Has No Idea How Much Money You Can Make Today (Sponsor)
The last few years made people forget how much banks and CD’s can pay. Meanwhile, interest rates have spiked and many can afford to pay you much more, but most are keeping yields low and hoping you won’t notice.
But there is good news. To win qualified customers, some accounts are paying almost 10x the national average! That’s an incredible way to keep your money safe and earn more at the same time. Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 3.80% with a Checking & Savings Account today Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.
Click here to see how much more you could be earning on your savings today. It takes just a few minutes to open an account to make your money work for you.
Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 4.00% with a Checking & Savings Account from Sofi. Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.